SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-17-014764
Filing Date
2017-08-15
Accepted
2017-08-14 18:00:54
Documents
3
Period of Report
2017-06-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A plxp20170813_8ka.htm 8-K/A 25588
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 172634
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 22814
  Complete submission text file 0001437749-17-014764.txt   222313
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36351 | Film No.: 171031922
SIC: 2834 Pharmaceutical Preparations